Active	Status	Sponsor type	Region	Phase	Filter
7 Active 17 Inactive 24 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jilma, Bernd
NCT05096403 / 2021-003160-27: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)	Suspended	3	57	Europe, Canada, Japan, US, RoW	Pegcetacoplan, Aspaveli	Swedish Orphan Biovitrum, Swedish Orphan Biovitrum AB	Cold Agglutinin Disease	10/24	10/24
NCT05021484 / 2021-000545-40: Felzartamab in Late Antibody-Mediated Rejection	Completed	2	22	Europe	Felzartamab, MOR202, CD38 monoclonal antibody, Placebo, 0.9% Saline	Farsad Eskandary, Charite University, Berlin, Germany, University of Alberta, HI-Bio	Antibody-mediated Rejection	03/24	03/24
NCT04941183: Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients	Terminated	1	52	Europe, RoW	NTR-441, Placebo	Neutrolis	Covid19	12/22	06/23
Schoergenhofer, Christian
No trials found
Riss, Katharina
No trials found
Schellongowski, Peter
No trials found
Bojic, Andja
No trials found
Staudinger, Thomas
No trials found